Evidence map›Paper›PMID 31031491›Full record

ArticleAnesthesia, essays and researches

Effect of Fentanyl and Nalbuphine for Prevention of Etomidate-Induced Myoclonus.

Megha Bisht, Abhimanyu Singh Pokhriyal, Gurjeet Khurana, Jagdish P Sharma

Open access · hybridAbstract read
In one paragraph

Article in Anesthesia, essays and researches. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Megha BishtDepartment of Anaesthesiology and Pain Management, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India.
Abhimanyu Singh PokhriyalDepartment of Anaesthesiology and Pain Management, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India.
Gurjeet KhuranaDepartment of Anaesthesiology and Pain Management, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India.
Jagdish P SharmaDepartment of Anaesthesiology and Pain Management, Himalayan Institute of Medical Sciences, Dehradun, Uttarakhand, India.
Swami Rama Himalayan University · INInstitute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEtomidate is a potent intravenous inducing agent with known undesirable side effects such as myoclonus and pain on injection in nonpremedicated patients.

aimsThe aim of this study is to compare the effect of fentanyl and nalbuphine in the prevention of etomidate-induced myoclonus. SETTINGS AND

designRandomized double-blind, placebo-controlled, and prospective comparative study. MATERIALS AND

methodsA total of 120 patients were randomly allocated to one of the three groups containing 40 patients each for intravenous administration of fentanyl 2 μg/kg diluted in 10 mL normal saline (NS) (Group 1), nalbuphine 0.3 mg/kg diluted in 10 mL NS (Group 2), and only 10 mL NS (Group 3) over 10 min. All groups subsequently received 0.3 mg/kg etomidate by intravenous bolus injection over 15-20 s and were assessed for the severity of pain using Grade IV pain scale and observed for myoclonus for 2 min and graded according to clinical severity. Serum creatinine phosphokinase (CPK) levels were obtained prior and postetomidate injection. STATISTICAL ANALYSIS: Statistical analysis was performed by the SPSS program version 17.0 for Windows. Tests used are Shaipro-Wilk test, ANOVA, Tukey's multiple comparison test, Tamhane's T2, and the Chi-square test. For all statistical tests,

resultsThe incidence of myoclonus in Group 1 and 2 was 52.5% and 17.5%, respectively, whereas it was 92.45% in Group 3. There was no pain observed in 70%, 92.5%, and 50% of patients in Group 1, 2, and 3, respectively. There was a statistically significant difference in mean CPK level after induction among three groups (

conclusionNalbuphine is more effective than fentanyl in the prevention of etomidate-induced myoclonus and pain with the minimum rise in CPK levels.

Indexed as

Creatinine phosphokinaseetomidatefentanylmiddle ear surgeriesmyoclonusnalbuphine

Identifiers

PMID31031491
PMCPMC6444973
OpenAlexW2941970205

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.